Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Super-short Course Regimen for Retreatment Pulmonary Tuberculosis
NCT02331823Phase 4Unknown
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Jun 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pasiniazid in pulmonary tuberculosis (TB), sponsored by Shanghai Pulmonary Hospital. Status: unknown.
02
Drugs
pasiniazid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02331823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02331823.